Nitazoxanide (CAS 55981-09-4)

Nitazoxanide, a broad-spectrum antiparasitic and antiviral agent, has gained prominence in scientific research for its multifaceted mechanisms of action. Primarily, it inhibits the activity of pyruvate:ferredoxin oxidoreductase (PFOR) enzyme, which is crucial for anaerobic energy metabolism in parasites. By disrupting PFOR, nitazoxanide interferes with the production of adenosine triphosphate (ATP), leading to energy depletion and eventual parasite death. Additionally, nitazoxanide modulates host cell signaling pathways, including the inhibition of viral replication through the disruption of viral protein maturation and trafficking. This dual mechanism of action makes nitazoxanide a promising candidate for research focused on understanding and combating various parasitic and viral infections. Researchers utilize nitazoxanide to explore its efficacy against a broad spectrum of pathogens, including protozoa, helminths, and viruses. Moreover, ongoing research investigates its potential as an agent in the management of parasitic and viral diseases, as well as its role in modulating host immune responses. Nitazoxanide′s versatile mechanisms of action and broad antiparasitic and antiviral activity continue to drive its exploration and application in scientific research aimed at addressing global health challenges.